Childhood Cancer

You are here

Home » Grants » All grants tagged with "Neuroblastoma"

All grants tagged with "Neuroblastoma"

Identification of TFAP4 (Transcription Factor AP-4/Activating Enhancer Binding Protein) as a Potential Master Regulator/Synthetic Lethal Gene of MYCN Amplified Neuroblastoma
Darrell Yamashiro, MD, PhD
Columbia University Medical Center
Innovation Grants, Awarded 2013
Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1
Loren Walensky, MD, PhD
Dana-Farber Cancer Institute
Innovation Grants, Awarded 2013
Therapeutically Targeting a Tumor Suppressor Complex in Aggressive Pediatric Cancers
Charles Roberts, MD, PhD
Dana-Farber Cancer Institute
Innovation Grants, Awarded 2013
Epigenetic Characterization of the Neuroblastoma Driver Genes ARID1A and ARID1B
Michael Hogarty, MD
Children’s Hospital of Philadelphia
Innovation Grants, Awarded 2013
An Oncolytic Herpes Simplex Virus Restricted in Entry to Neuroblastoma Cells
Richard Longnecker, PhD
Northwestern University Medical School
Innovation Grants, Awarded 2013
Nanoparticle Delivery of Therapeutic Agents in Neuroblastomas
Garrett M. Brodeur, MD
Children’s Hospital of Philadelphia
Innovation Grants, Awarded 2013
Clinical Epidemiology Studies in Children's Oncology Group Clinical Trials
Richard Aplenc, MD, PhD, MSCE
Children’s Hospital of Philadelphia
Epidemiology Grants, Awarded 2013
The Role of PTPRD as a Tumor Suppressor in Neuroblastoma Pathogenesis
Shizhen Zhu, MD, PhD
Mayo Clinic
Young Investigator Grants, Awarded 2013
Defining the Mechanism by which LIN28B acts as an Oncogene in Neuroblastoma
Robert Schnepp, MD, PhD
Children’s Hospital of Philadelphia
Young Investigator Grants, Awarded 2013
Characterization of the Role of Chromosome 1p Deletion in MYCN-Amplified Neuroblastoma
Miller Huang, PhD
University of California San Francisco
Young Investigator Grants, Awarded 2013

Pages

All childhood cancer types

Featured Hero

Ayla Castro

Little Ayla loves animals and anything princesses! When Ayla started looking pale, developed random bruises, and did not want to walk, her parents knew something was wrong. Today, Ayla is bravely undergoing treatment for acute lymphoblastic leukemia.
Read more »